Phenotype of cerebellar glutamatergic neurons is altered in stargazer mutant mice lacking brain-derived neurotrophic factor mRNA expression
- PMID: 15562504
- DOI: 10.1002/cne.20386
Phenotype of cerebellar glutamatergic neurons is altered in stargazer mutant mice lacking brain-derived neurotrophic factor mRNA expression
Abstract
Brain-derived neurotrophic factor (BDNF) influences neuronal survival, differentiation, and maturation. More recently, its role in synapse formation and plasticity has also emerged. In the cerebellum of the spontaneous recessive mutant mouse stargazer (stg) there is a specific and pronounced deficit in BDNF mRNA expression. BDNF protein levels in the cerebellum as a whole are reduced by 70%, while in the granule cells (GCs) there is a selective and near total reduction in BDNF mRNA expression. Recently, we published data demonstrating that inhibitory neurons in the cerebella of stgs have significantly reduced levels (approximately 50%) of gamma-aminobutyric acid (GABA) and fewer, smaller inhibitory synapses compared to wildtype (WT) controls. Our current investigations indicate that the stargazer mutation has an even more pronounced effect on the phenotype of glutamatergic neurons in the cerebellum. There is a profound decrease in the levels of glutamate-immunoreactivity (up to 77%) in stg compared to WT controls. The distribution profile of presynaptic vesicles is also markedly different: stgs have proportionally fewer docked vesicles and fewer vesicles located adjacent to the active zone ready to dock than WTs. Furthermore, the thickness of the postsynaptic density (PSD) at mossy fiber-granule cell (MF-GC) and parallel fiber-Purkinje cell (PF-PC) synapses is severely reduced (up to 33% less than WT controls). The number and length of excitatory synapses, however, appear to be relatively unchanged. It is possible that at least some of theses changes in phenotype are directly attributable to the lack of BDNF in the cerebellum of the stg mutant.
2004 Wiley-Liss, Inc.
Similar articles
-
Cerebellar Golgi, Purkinje, and basket cells have reduced gamma-aminobutyric acid immunoreactivity in stargazer mutant mice.J Comp Neurol. 2002 Nov 4;453(1):85-99. doi: 10.1002/cne.10406. J Comp Neurol. 2002. PMID: 12357434
-
Selective reduction in synaptic proteins involved in vesicle docking and signalling at synapses in the ataxic mutant mouse stargazer.J Comp Neurol. 2009 Jan 1;512(1):52-73. doi: 10.1002/cne.21890. J Comp Neurol. 2009. PMID: 18972569
-
Differential regulation of glutamate receptor-mediated BDNF mRNA expression in the cerebellum and its defects in stargazer mice.Neuropharmacology. 2007 Jul;53(1):81-91. doi: 10.1016/j.neuropharm.2007.04.012. Epub 2007 May 1. Neuropharmacology. 2007. PMID: 17544459
-
Cerebellar synaptogenesis: mutant mice--neuronal grafting.J Physiol (Paris). 1991;85(3):134-44. J Physiol (Paris). 1991. PMID: 1818110 Review.
-
Subcellular regulation of metabotropic GABA receptors in the developing cerebellum.Cerebellum. 2007;6(2):123-9. doi: 10.1080/14734220601039157. Cerebellum. 2007. PMID: 17510912 Review.
Cited by
-
TRK inhibitors in TRK fusion-positive cancers.Ann Oncol. 2019 Nov 1;30(Suppl_8):viii23-viii30. doi: 10.1093/annonc/mdz282. Ann Oncol. 2019. PMID: 31738426 Free PMC article. Review.
-
The alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor trafficking regulator "stargazin" is related to the claudin family of proteins by Its ability to mediate cell-cell adhesion.J Biol Chem. 2005 May 20;280(20):19711-20. doi: 10.1074/jbc.M500623200. Epub 2005 Mar 10. J Biol Chem. 2005. PMID: 15760900 Free PMC article.
-
Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.Brain Res. 2009 Apr 17;1266:93-107. doi: 10.1016/j.brainres.2009.02.009. Epub 2009 Feb 20. Brain Res. 2009. PMID: 19230832 Free PMC article.
-
Stargazin (TARP gamma-2) is required for compartment-specific AMPA receptor trafficking and synaptic plasticity in cerebellar stellate cells.J Neurosci. 2011 Mar 16;31(11):3939-52. doi: 10.1523/JNEUROSCI.5134-10.2011. J Neurosci. 2011. PMID: 21411637 Free PMC article.
-
Characterization of on-target adverse events caused by TRK inhibitor therapy.Ann Oncol. 2020 Sep;31(9):1207-1215. doi: 10.1016/j.annonc.2020.05.006. Epub 2020 May 15. Ann Oncol. 2020. PMID: 32422171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous